MedTrace Logo

Measuring the Impact of a Mobile Health System to Support Healthy Pregnancies and Improve Newborn Survival

NCT02909179 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 113539

Last updated 2023-07-17

No results posted yet for this study

Summary

The purpose of this community-based randomized controlled trial is to test whether the mCARE-II intervention package, delivered by the existing Government of Bangladesh community health workforce, will improve neonatal and perinatal survival in a rural setting in northwestern Bangladesh. mCARE-II is a digital health intervention, which incorporates automated workload scheduling, client prioritization and risk stratification, overdue service reminders and demand generation through client side reminder messaging. The intervention package focuses on the pregnancy and early postpartum period.

Conditions

  • High Perinatal Mortality
  • High Neonatal Mortality
  • Low Antenatal Care Service Utilization
  • Low Postnatal Care Service Utilization

Interventions

OTHER

mCARE-II

mCARE-II is a package of interventions that provides guided client enumeration and follow-up support to community health workers, automated workflow scheduling, risk assessment, client prioritization and stratification and client-based demand generation messaging. These features are incorporated into a platform called OpenSRP, which integrates text message reminders, scheduling, and form submissions on the server side, and displays schedules and client lists on a tablet-based application for community health workers.

Sponsors & Collaborators

  • mPower Social Enterprises Limited

    collaborator UNKNOWN

  • The JiVitA Project

    collaborator UNKNOWN

  • Johns Hopkins Bloomberg School of Public Health

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2020-12-22
Completion
2020-12-22

Countries

  • Bangladesh

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02909179 on ClinicalTrials.gov